Kazia Therapeutics (KZIA) Enterprise Value Growth (5y) (2014 - 2025)

Kazia Therapeutics (KZIA) Enterprise Value Growth (5y) (2014 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Kazia Therapeutics 4.11 Mn 4.11 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -17.67%
Jun 30, 2025 23.56%
Dec 31, 2024 5.01%
Jun 30, 2024 21.70%
Dec 31, 2023 3.80%
Jun 30, 2023 4.92%
Jun 30, 2022 13.45%
Dec 31, 2021 -17.30%
Jun 30, 2021 -1.00%
Dec 31, 2020 9.06%
Jun 30, 2020 21.04%
Dec 31, 2019 -10.72%
Jun 30, 2019 -8.04%
Dec 31, 2018 15.38%
Jun 30, 2018 -10.64%
Jun 30, 2017 -9.88%
Dec 31, 2016 24.45%
Jun 30, 2016 -32.21%
Dec 31, 2015 -16.26%
Jun 30, 2015 -14.62%